Management of refractory esophageal stenosis in the pediatric age

Rev Esp Enferm Dig. 2016 Oct;108(10):627-636. doi: 10.17235/reed.2016.3671/2015.

Abstract

Introduction: Refractory esophageal stenosis (RES) is a major health problem in the pediatric population. Several techniques such as stent placement or C-mitomycin (CM) have been described as alternative treatments. We present our experience with both techniques, in our case with biodegradable stents (BS) and sometimes the association with stents and CM.

Material and methods: Six patients have been included: 2 post-operative fistulas in patients with type I esophageal atresia; 1 operated atresia without fistula; and 3 caustic strictures. 5 BS were placed in 4 children: 3 of them in cases of atresia (2 prosthesis in one case) and the other one in a case of stricture. CM was used in 5 cases: in 2 of them from the beginning, and in the other 3 cases after failure of the stent.

Results: When placed in fistulas, BS were fully covered. One of them successfully treated the fistula, but the other one was not effective. One stenosis was successfully treated with SB (in the case of persistent fistula), but recurrence was observed in the other 2 cases. One of these was solved with CM, and the other one needed a second stent. In the remaining 2 cases (one atresia and one caustic stricture) CM was effective after 1 and 2 sessions respectively. Overall, 5 out of 6 stenosis have been successfully treated (83.3%), and 1 out of 2 fistulas (50%).

Conclusions: Association of BS and CM has been effective in the management of RES in children.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibiotics, Antineoplastic / therapeutic use
  • Child
  • Child, Preschool
  • Drug Resistance
  • Esophageal Atresia / complications
  • Esophageal Atresia / surgery
  • Esophageal Fistula / complications
  • Esophageal Fistula / surgery
  • Esophageal Stenosis / etiology
  • Esophageal Stenosis / therapy*
  • Female
  • Humans
  • Infant
  • Male
  • Mitomycin / therapeutic use
  • Postoperative Complications / therapy
  • Prosthesis Implantation
  • Stents

Substances

  • Antibiotics, Antineoplastic
  • Mitomycin